Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 6/16/21 → 1/7/25 |
Funding
- PPD Investigator Services LLC: $2,387,935.00
Covid 19: A Phase 2/3, Two-Part, Open-Label, Dose-Escalation, Age De-escalation and Randomized, Oberver-Blind, Placebo-Controlled Expansion Study to Evaluate the Safety, Tolerability, Reactogenicity, and Effectiveness of mRNA-1273 SARS-CoV-2 Vaccine
- Fuchs, George (PI)
- Bauer, John (CoI)
- Desai, Nirmala (CoI)
- Greenberg, Richard (CoI)
- Robbins, Susan (CoI)
- Simmons, Christopher (CoI)
- Wurth, Mark (CoI)